<DOC>
	<DOCNO>NCT00335218</DOCNO>
	<brief_summary>The aim study explore effect hormone replacement therapy EV/DNG abdominal fat distribution measure magnetic resonance imaging .</brief_summary>
	<brief_title>Fat Distribution Healthy Early Postmenopausal Women</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Estradiol Valerate , dienogest drug combination</mesh_term>
	<criteria>Healthy early postmenopausal woman BMI 25 30 Contraindication ( ) hormone treatment Metabolic diseases Concomitant medication influence lipid metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Early postmenopausal state</keyword>
	<keyword>Climacteric symptom</keyword>
	<keyword>Hormone replacement therapy</keyword>
</DOC>